US Bancorp’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

US Bancorp’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-344,358	Closed	-$35.2M	–	3758
2014 Q4	$35.2M	Sell	344,358 -6,257	-2%	-$600K	0.14%	142
2014 Q3	$30.3M	Buy	350,615 +4,323	+1%	+$383K	0.12%	147
2014 Q2	$31.2M	Sell	346,292 -30,128	-8%	-$2.25M	0.12%	145
2014 Q1	$27.7M	Buy	376,420 +19,412	+5%	+$1.35M	0.11%	159
2013 Q4	$24.3M	Buy	357,008 +26,373	+8%	+$1.72M	0.1%	169
2013 Q3	$20.1M	Sell	330,635 -37,257	-10%	-$2.27M	0.09%	177
2013 Q2	$20.5M	Buy	+367,892	New	+$21.3M	0.09%	167

US Bancorp's COV Position: Q1 2015 in Review

US Bancorp sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 344,358 shares — an estimated $35.2M sold.

US Bancorp first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $35.2M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

US Bancorp reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
US Bancorp sold 344,358 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $35.2M.
US Bancorp first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
US Bancorp's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $35.2M in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on US Bancorp's 13F filing for Q1 2015, filed 8 May 2015.